Not medical advice. This site explains research. It is not a diagnosis, a dose, or a treatment plan.

Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 96/100Confidence medium

Methylglyoxal glycates mitochondrial complex I, and a mitochondrial NADH oxidase eases diabetic pain in mice

Not medical advice. This brief explains a preprint. It is not a diagnosis, a dose, or a treatment plan.

Painful diabetic neuropathy is tied to methylglyoxal, a reactive product of glycolysis. This preprint reports that methylglyoxal glycates mitochondrial complex I, raises NADH against NAD+, and turns on the kinase GCN2. Correcting the NADH excess inside mitochondria, or blocking GCN2 in sensory neurons, reduced mechanical pain in a mouse model. The abstract does not name which complex I cofactor was modified.

Mito.news · at a glance

Signal profile (abstract-level)

complex I · diabetic neuropathy · integrated stress response · NADH

Score 96/100BIORXIVmedium confidencecomplex I
96
Importance
77
Mito signal
67
Dysfunction
83
Evidence
30
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Methylglyoxal is a reactive side product of glycolysis, and it is already associated with painful diabetic neuropathy. This preprint argues that the pain signal is a mitochondrial redox change that turns on a translation kinase.

In human sensory neurons derived from dorsal root ganglia, methylglyoxal increased phosphorylation of the translation factor eIF2 alpha and suppressed global protein synthesis. Inhibiting GCN2, general control nonderepressible 2, blocked both effects. The authors present GCN2 as the sensor that joins glycolytic stress and mitochondrial stress to the integrated stress response.

Ribosome profiling of mouse dorsal root ganglia showed that methylglyoxal repressed messenger RNAs encoding parts of the electron transport chain. That result pointed upstream of the kinase. Methylglyoxal directly glycated mitochondrial complex I and raised the ratio of NADH to NAD+. Expressing mitoLbNOX, a bacterial NADH oxidase aimed at mitochondria, corrected that imbalance and stopped the stress response from turning on.

In mice given streptozotocin, a drug that produces diabetic neuropathy in this model, a GCN2 inhibitor or deletion of GCN2 in sensory neurons reduced mechanical allodynia. Neurons without GCN2 also took in less calcium when a TRPA1 agonist was applied. An adeno-associated virus that expressed mitoLbNOX in dorsal root ganglion neurons reduced the same mechanical hypersensitivity.

Metal and redox

The machine named in the abstract is mitochondrial complex I. The chemical change they report is glycation of that complex. The redox couple they report is NADH against NAD+. They do not name an iron-sulfur cluster, a flavin, or a copper site, so this account does not assign one. GCN2 is a kinase in this story, not a metallocofactor.

What this does not show

The paper is a preprint, and this account uses the abstract. It does not say which part of complex I was glycated. The pain behavior is a mouse streptozotocin model plus cultured human sensory neurons. Nothing here is a dose, a protocol, or a treatment plan.

Free HTML is above. Bots pay for JSON at /api/v1/papers/10-64898-2026-11-11-765941. Optional wallet tester: MetaMask ($0.005).

Source preprint

Mitochondrial dysfunction activates a translational stress response that drives diabetic pain

10.64898/2026.11.11.765941

Meyer AR, Garcia G, Ruhly S, Mikesell AR, Shapiro JB, Chase R, Campbell ZT.

Related briefs